×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COGT – cogent biosciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COGT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
07:20 am
cogt
We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Cogent Biosciences' (NASDAQ:COGT) Cash Burn Rate [Yahoo! Finance]
3/25
04:31 pm
cogt
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
Medium
Report
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
3/11
07:45 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
3/7
09:13 am
cogt
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference [Yahoo! Finance]
Medium
Report
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference [Yahoo! Finance]
3/7
08:17 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
Medium
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $17.00 price target on the stock.
3/7
08:00 am
cogt
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
Medium
Report
Cogent Biosciences Announces Participation in the Leerink Healthcare Conference
2/27
08:08 am
cogt
Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target lowered by analysts at Robert W. Baird from $10.00 to $8.00. They now have a "neutral" rating on the stock.
High
Report
Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target lowered by analysts at Robert W. Baird from $10.00 to $8.00. They now have a "neutral" rating on the stock.
2/27
08:00 am
cogt
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
High
Report
Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/25
04:02 pm
cogt
Form S-8 Cogent Biosciences, Inc.
Medium
Report
Form S-8 Cogent Biosciences, Inc.
2/25
08:39 am
cogt
Form 10-K Cogent Biosciences, Inc. For: Dec 31
Medium
Report
Form 10-K Cogent Biosciences, Inc. For: Dec 31
2/25
08:20 am
cogt
Form 8-K Cogent Biosciences, Inc. For: Feb 25
Medium
Report
Form 8-K Cogent Biosciences, Inc. For: Feb 25
2/14
04:11 pm
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
2/12
04:36 pm
cogt
Form SCHEDULE 13G Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SCHEDULE 13G Cogent Biosciences, Inc. Filed by: Paradigm Biocapital Advisors LP
2/12
09:28 am
cogt
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Cogent Biosciences, Inc. Filed by: FMR LLC
1/27
05:04 pm
cogt
Form 4 Cogent Biosciences, Inc. For: Jan 23 Filed by: Green John L.
Medium
Report
Form 4 Cogent Biosciences, Inc. For: Jan 23 Filed by: Green John L.
1/27
05:00 pm
cogt
Form 4 Cogent Biosciences, Inc. For: Jan 23 Filed by: Pinnow Cole
Medium
Report
Form 4 Cogent Biosciences, Inc. For: Jan 23 Filed by: Pinnow Cole
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: